Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy

Human Molecular Genetics

Volumn 18, Issue 18, 2009, Pages 3439-3451

  Wehling Henricks, Michelle ^a   Oltmann, Meredith ^a   Rinaldi, Chiara ^a   Myung, Kyu H ^b   Tidball, James G ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Chonnam National University   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLAVINE ADENINE NUCLEOTIDE; GLYCOGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE;

ALLOSTERISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ENZYME SPECIFICITY; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE INTERACTION; GLYCOGEN METABOLISM; GLYCOLYSIS; MOUSE; MUSCLE EXERCISE; MUSCLE FATIGUE; MUSCLE PERFUSION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; TRANSGENE; TREADMILL EXERCISE;

ALLOSTERIC REGULATION; ANIMALS; FLAVIN-ADENINE DINUCLEOTIDE; GLYCOGEN; GLYCOLYSIS; MICE; MICE, INBRED MDX; MICE, TRANSGENIC; MODELS, MOLECULAR; MUSCULAR DYSTROPHIES; NITRIC OXIDE SYNTHASE TYPE I; PHOSPHOFRUCTOKINASES; PHYSICAL CONDITIONING, ANIMAL; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SUBSTRATE SPECIFICITY;

MUS;

EID: 69449101150     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp288     Document Type: Article

References (58)

1. Brenman, J.E., Chao, D.S., Xia, H., Aldape, K. and Bredt, D.S. (1995) Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell, 82, 743-752.
2. Chang, W.J., Iannaccone, S.T., Lau, K.S., Masters, B.S., McCabe, T.J., McMillan, K., Padre, R.C., Spencer, M.J., Tidball, J.G. and Stull, J.T. (1996) Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc. Natl Acad. Sci. USA, 93, 9142-9147.
3. Thomas, G.D., Sander, M., Lau, K.S., Huang, P.L., Stull, J.T. and Victor, R.G. (1998) Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc. Natl Acad. Sci. USA, 95, 15090-15095.
4. Sander, M., Chavoshan, B., Harris, S.A., Iannaccone, S.T., Stull, J.T., Thomas, G.D. and Victor, R.G. (2000) Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc. Natl Acad. Sci. USA, 97 13818-13823.
5. Wehling, M., Spencer, M.J. and Tidball, J.G. (2001) A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J. Cell Biol., 155, 123-131.
6. Wehling-Henricks, M., Sokolow, S., Lee, J.J., Myung, K.H., Villalta, S.A. and Tidball, J.G. (2008) Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy. Hum. Mol. Genet., 17, 2280-2292.
7. Wehling-Henricks, M., Jordan, M.C., Roos, K.P., Deng, B. and Tidball, J.G. (2005) Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium. Hum. Mol. Genet., 14, 1921-1933.
8. Shiao, T., Fond, A., Deng, B., Wehling-Henricks, M., Adams, M.E., Froehner, S.C. and Tidball, J.G. (2004) Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins. Hum. Mol. Genet., 13, 1873-1884.
9. Wozniak, A.C. and Anderson, J.E. (2007) Nitric oxide-dependence of satellite stem cell activation and quiescence on normal skeletal muscle fibers. Dev. Dyn., 236, 240-250.
10. Deng, B., Glanzman, D. and Tidball, J.G. (2009) Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy. J. Physiol. (Lond.), 587, 1769-1778.
11. Thum, T. and Bauersachs, J. (2007) Microarray-based gene expression profiling to elucidate cellular responses to nitric oxide-a review from an analytical and biomedical point of view. J. Chromatogr. B. Anal. Technol. Biomed. Life Sci., 851, 3-11.
12. Frascarelli, M., Rocchi, L. and Feola, I. (1998) EMG computerized analysis of localized fatigue in Duchenne muscular dystrophy. Muscle Nerve, 11, 757-761.
13. Wineinger, M.A., Abresch, R.T., Walsh, S.A. and Carter, G.T. (1998) Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice. Am. J. Phys. Med. Rehabil., 77, 20-27.
14. Percival, J.M., Anderson, K.N., Gregorevic, P., Chamberlain, J.S. and Froehner, S.C. (2008) Functional deficits in nNOSmu-deficient skeletal muscle: Myopathy in nNOS knockout mice. PLoS ONE, 3, e3387.
15. Kobayashi, Y.M., Rader, E.P., Crawford, R.W., Iyengar, N.K., Thedens, D.R., Faulkner, J.A., Parikh, S.V., Weiss, R.M., Chamberlain, J.S., Moore, S.A. and Campbell, K.P. (2008) Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature, 456 511-515.
16. Zhu, X., Heunks, L.M., Ennen, L., Machiels, H.A., Van Der Heijden, H.F. and Dekhuijzen, P.N. (2006) Nitric oxide modulates neuromuscular transmission during hypoxia in rat diaphragm. Muscle Nerve, 33 104-112.
17. Nisoli, E., Clementi, E., Paolucci, C., Cozzi, V., Tonello, C., Sciorati, C., Bracale, R., Valerio, A., Francolini, M., Moncada, S. and Carruba, M.O. (2003) Mitochondrial biogenesis in mammals: The role of endogenous nitric oxide. Science, 299, 896-899.
18. Lira, V.A., Soltow, Q.A., Long, J.H., Betters, J.L., Sellman, J.E. and Criswell, D.S. (2007) Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle. Am. J. Physiol. Endocrinol. Metab., 293, E1062-E1068.
19. Firestein, B.L. and Bredt, D.S. (1999) Interaction of neuronal nitric-oxide synthase and phosphofructokinase-M. J. Biol. Chem., 274, 10545-10550.
20. Chi, M.M., Hintz, C.S., McKee, D., Felder, S., Grant, N., Kaiser, K.K. and Lowry, O.H. (1987) Effect of Duchenne muscular dystrophy on enzymes of energy metabolism in individual muscle fibers. Metabolism, 36, 761-767.
21. Andersen, K.L., Lund-Johansen, P. and Clausen, G. (1969) Metabolic and circulatory responses to muscular exercise in a subject with glycogen storage disease (McArdle's Disease). Scand. J. Clin. Lab. Invest., 24, 105-113.
22. Kono, N., Mineo, I., Shimizu, T., Hara, N., Yamada, Y., Nonaka, K. and Tarui, S. (1986) Increased plasma uric acid after exercise in muscle phosphofructokinase deficiency. Neurology, 36, 106-108.
23. Lewis, S.F. and Haller, R.G. (1989) Skeletal muscle disorders and associated factors that limit exercise performance. Exerc. Sport Sci. Rev., 17, 67-113.
24. Lau, K.S., Grange, R.W., Isotani, E., Sarelius, I.H., Kamm, K.E., Huang, P.L. and Stull, J.T. (2000) nNOS and eNOS modulate cGMP formation and vascular response in contracting fast-twitch skeletal muscle. Physiol. Genomics, 2, 21-27.
25. Oliver, L., Goureau, O., Courtois, Y. and Vigny, M. (1996) Accumulation of NO synthase (type-I) at the neuromuscular junctions in adult mice. Neuroreport, 7, 924-926.
26. Zhang, J., Martàsek, P., Paschke, R., Shea, T., Siler Masters, B.S. and Kim, J.J. (2001) Crystal structure of the FAD/NADPH-binding domain of rat neuronal nitric-oxide synthase. Comparisons with NADPH-cytochrome P450 oxidoreductase. J. Biol. Chem., 276, 37506-37513.
27. Gnanapandithen, K., Chen, Z., Kau, C.-L., Gorczynski, R.M. and Marsden, P.A. (1996) Cloning and characterization of murine endothelial constitutive nitric oxide synthase. Biochim. Biophys. Acta, 1308, 103-106.
28. Xie, Q.-W., Cho, H.J., Calaycay, J., Mumford, R.A., Swiderek, K.M., Lee, T.D., Ding, A., Troso, T. and Nathan, C. (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science, 256, 225-228.
29. Hays, A.P., Hallett, M., Delfs, J., Morris, J., Sotrel, A., Shevchuk, M.M. and DiMauro, S. (1981) Muscle phosphofructokinase deficiency: abnormal polysaccharide in a case of late-onset myopathy. Neurology 31, 1077-1086.
30. Vorgerd, M., Karitzky, J., Ristow, M., Van Schaftingen, E., Tegenthoff, M., Jerusalem, F. and Malin, J.P. (1996) Muscle phosphofructokinase deficiency in two generations. J. Neurol. Sci., 141, 95-99.
31. Nakajima, H., Raben, N., Hamaguchi, T. and Yamasaki, T. (2002) Phosphofructokinase deficiency; past, present and future. Curr. Mol. Med., 2, 197-212.
32. Newman, R.J., Bore, P.J., Chan, L., Gadian, D.G., Styles, P., Taylor, D. and Radda, G.K. (1982) Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy. Br. Med. J., 284, 1072-1074.
33. 31P NMR studies in Duchenne muscular dystrophy: Age-related metabolic changes. Neurology, 37, 165-169.
34. Kemp, G.J., Taylor, D.J., Dunn, J.F., Frostick, S.P. and Radda, G.K. (1993) Cellular energetics of dystrophic muscle. J. Neurol. Sci., 116, 201-206.
35. 31P NMR study. Neuromuscul. Disord., 8, 371-379.
36. Dunn, J.F., Frostick, S., Brown, G. and Radda, G.K. (1991) Energy status of cells lacking dystrophin: An in vivo/in vitro study of mdx mouse skeletal muscle. Biochim. Biophys. Acta, 1096, 115-120.
37. Dunn, J.F., Tracey, I. and Radda, G.K. (1992) 31P-NMR study of muscle exercise metabolism in mdx mice: Evidence for abnormal pH regulation. J. Neurol. Sci., 113, 108-113.
38. Dunn, J.F., Tracey, I. and Radda, G.K. (1993) Exercise metabolism in Duchenne muscular dystrophy: A biochemical and [31P]-nuclear magnetic resonance study of mdx mice. Proc. Biol. Sci., 251, 201-206.
39. Chen, Y-W., Zhao, P., Borup, R. and Hoffman, E.P. (2000) Expression profiling in the muscular dystrophies: Identification of novel aspects of molecular pathophysiology. J. Cell Biol., 11, 1321-1336.
40. Tkatchenko, A.V., Piétu, G., Cros, N., Gannoun-Zaki, L., Auffray, C., Léger, J.J. and Dechesne, C.A. (2001) Identification of altered gene expression in skeletal muscles from Duchenne muscular dystrophy patients. Neuromuscul. Disord., 11, 269-277.
41. Robert, V., Massimino, M.L., Tosello, V., Marsault, R., Cantini, M., Sorrentino, V. and Pozzan, T. (2001) Alteration in calcium handling at the subcellular level in mdx myotubes. J. Biol. Chem., 276, 4647-4651.
42. Ruegg, U.T., Nicolas-Métral, V., Challet, C., Bernard-Hélary, K., Dorchies, O.M., Wagner, S. and Buetler, T.M. (2002) Pharmacological control of cellular calcium handling in dystrophic skeletal muscle. Neuromuscul. Disord., 12, S155-S161.
43. Cole, M.A., Rafael, J.A., Taylor, D.J., Lodi, R., Davies, K.E. and Styles, P. (2002) A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin. Neuromuscul. Disord., 12, 247-257.
44. Lodi, R., Kemp, G.J., Muntoni, F., Thompson, C.H., Rae, C., Taylor, J., Styles, P. and Taylor, D.J. (1999) Reduced cytosolic acidification during exercise suggests defective glycolytic activity in skeletal muscle of patients with Becker muscular dystrophy. An in vivo 31P magnetic resonance spectroscopy study. Brain, 122, 121-130.
45. Sharma, U., Atri, S., Sharma, M.C., Sarkar, C. and Jagannathan, N.R. (2003) Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD): an in-vitro proton NMR spectroscopy study. Magn. Reson. Imaging, 21, 145-153.
46. Venkatasubramanian, P.N., Arus, C. and Barany, M. (1986) Two-dimensional proton magnetic resonance of human muscle extracts. Clin. Physiol. Biochem., 4, 1-7.
47. Almeida, A., Moncada, S. and Bolaños, J.P. (2004) Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway. Nat. Cell Biol., 6, 45-51.
48. Nagel, A., Lehmann-Horn, F. and Engel, A.G. (1990) Neuromuscular transmission in the mdx mouse. Muscle Nerve, 13, 742-749.
49. Amalfitano, A. and Chamberlain, J.S. (1996) The mdx-amplification-resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx allele. Muscle Nerve, 19, 1549-1553.
50. Tidball, J.G. and Wehling-Henricks, M. (2004) Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Mol. Genet. Metab., 82, 312-320.
51. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
52. Minamide, L.S. and Bamburg, J.R. (1990) A filter paper dye-binding assay for quantitative determination of protein without interference from reducing agents or detergents. Anal. Biochem., 190, 66-70.
53. Ling, K.H., Marcus, F. and Lardy, H.A. (1965) Purification and some properties of rabbit skeletal muscle phosphofructokinase. J. Biol. Chem., 240, 1893-1899.
54. Mansour, T.E. (1972) Phosphofructokinase activity in skeletal muscle extracts following administration of epinephrine. J. Biol. Chem., 247, 6059-6066.
55. Passonneau, J. and Lauderdale, V. (1974) A comparison of 3 methods of glycogen measurement in tissues. Anal. Biochem., 60, 405-412.
56. Asllani, I., Shankland, E., Pratum, T. and Kushmerick, M. (1999) Anisotropic orientation of lactate in skeletal muscle observed by dipolar coupling in 1H NMR spectroscopy. J. Magn. Reson., 139 213-224.
57. Severn, D.J., Johnson, M.E. and Olson, N.F. (1985) Determination of lactic acid in cheddar cheese and calcium lactate crystals. J. Diary Sci., 69, 2027-2030.
58. Ownby, C.L., Colberg, T.R. and Odell, G.V. (1984) A new method for quantitating hemorrhage induced by rattlesnake venoms: Ability of polyvalent antivenom to neutralize hemorrhagic activity. Toxicon, 22, 227-233.